
Benefits of booster campaigns questionable
While Pfizer Inc and BioNTech SE financial outlooks in February prognosed more than $50bn in combined coronavirus disease (COVID-19) vaccine sales in...

Cradle BV bags €5.4m in seed financing
Cradle BV has raised $5.4m to push a machine-learning model-based platform that helps scientists to design and program cells much faster in order to...

Ultra-processed foods increase risk for cancer
According to a long-term data from the UK biobank, high consumption of ultra-processed foods are linked to bad health outcomes such as diabetes,-...

British AI provider raises $33m in Series A financing
Existing investors Air Street Capital, Amadeus Capital Partners, and Partech also participated in the large Series A financing round. V7's platform...

First allogeneic cancer immunotherapy hits market
On December 20th, the European Commission approved Tabelecleucel (EbvalloTM) as a monotherapy for the treatment of adult and paediatric patients who...

Novo Nordisk funds API manufacturing with €726m
Novo Nordisk’s latest expansion of R&D as well as production capacity is motivated by the need to generate more of its GLP-1 agonist semaglutide,...

Partnering revitalized at the BioFit2022 – in Strasbourg and online
A biologist, a CEO, and a venture capitalist enter the BioFit2022 event...., while this may sound like the beginning of a great joke, it fits the...